Strides Pharma Science Limited has informed the Exchange regarding Outcome of Board Meeting held on May 18, 2026.
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Strides Pharma Science's Board has recommended appointing Deloitte Haskins & Sells LLP as the new Statutory Auditors for a 5-year term from FY28 to FY32. The current auditors, B S R & Co. LLP, are completing their second consecutive 5-year term (10 years total) at the conclusion of the 36th AGM in 2027. The appointment is subject to shareholder approval at the 36th AGM. This is a mandatory auditor rotation as per SEBI regulations, which require rotation after 10 years.
This is a routine corporate governance action with no immediate material impact on the stock. The rotation to a Big Four firm (Deloitte) may signal enhanced audit quality standards going forward.